Početna › Rak želuca
Kliničke studije za Rak želuca koje traže sudionike u SAD-u
134 studija za Rak želuca traži sudionike na lokacijama širom Sjedinjenih Američkih Država.
Gradovi s najviše studija
- Houston, TX42 studija
- Boston, MA32 studija
- New York City, NY31 studija
- Nashville, TN28 studija
- Los Angeles, CA22 studija
- Baldwin Park, CA22 studija
- Arlington, VA20 studija
- Dallas, TX19 studija
- San Antonio, TX19 studija
- Grand Rapids, MI18 studija
- St. Louis, MO18 studija
- Washington, DC16 studija
- Detroit, MI16 studija
- Chicago, IL16 studija
- Philadelphia, PA15 studija
- Atlanta, GA14 studija
- Pittsburgh, PA14 studija
- Portland, OR13 studija
- Orange, CA13 studija
- Denver, CO12 studija
- Mountain View, CA12 studija
- Cleveland, OH12 studija
- Madison, WI11 studija
- Austin, TX10 studija
- Orlando, FL10 studija
- Queens, NY10 studija
- Seattle, WA10 studija
- Durham, NC10 studija
- Aurora, CO10 studija
- Oklahoma City, OK10 studija
- Edison, NJ9 studija
- Phoenix, AZ9 studija
- San Diego, CA9 studija
- Omaha, NE9 studija
- Kansas City, MO9 studija
- Tampa, FL9 studija
- Columbus, OH9 studija
- Santa Monica, CA9 studija
- Rochester, MN9 studija
- Minneapolis, MN9 studija
Po državama
- Alabama6 studija
- Aljaska4 studija
- Arizona13 studija
- Arkansas6 studija
- Colorado23 studija
- Connecticut10 studija
- Delaware4 studija
- Distrikt Columbia4 studija
- Florida38 studija
- Georgia16 studija
- Idaho3 studija
- Illinois19 studija
- Indiana10 studija
- Iowa8 studija
- Kalifornija69 studija
- Kansas8 studija
- Kentucky9 studija
- Louisiana5 studija
- Maine3 studija
- Maryland20 studija
- Massachusetts34 studija
- Michigan35 studija
- Minnesota18 studija
- Missouri23 studija
- Montana4 studija
- Nebraska9 studija
- Nevada5 studija
- New Jersey12 studija
- New Mexico5 studija
- New York38 studija
- North Carolina21 studija
- North Dakota4 studija
- Ohio24 studija
- Oklahoma11 studija
- Oregon14 studija
- Pennsylvania30 studija
- Rhode Island5 studija
- South Carolina9 studija
- South Dakota4 studija
- Tennessee30 studija
- Texas60 studija
- Utah14 studija
- Virginia27 studija
- Washington14 studija
- West Virginia4 studija
- Wisconsin18 studija
Nedavno ažurirane studije
Službeni tekst studije (engleski)
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
U tijeku regrutacijaOpažajna studija
Od 2 do 100 godina · Oba spola · Ažurirano 2. lis 2026. · NCT01950572Distance-Based Exercise to Preserve Function and Prevent Disability
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07059884Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07283939Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
U tijeku regrutacijaFaza 1
Od 18 do 120 godina · Oba spola · Ažurirano 2. lis 2026. · NCT06885697Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT07529808Surgery in Gastrointestinal Stromal Tumors (GISTs) for Treatment, Tumor Modeling, and Genomic Analysis
U tijeku regrutacijaOpažajna studija
Od 6 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT04557969Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06760819A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
U tijeku regrutacijaFaza 1
Od 19 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06586957Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer
U tijeku regrutacijaOpažajna studija
Od 2 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT01915225A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06172478A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07221149AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT06219941A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT07814248Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07700979Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07360314A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 29. ruj 2026. · NCT07578571IKS014 in Advanced Solid Tumors That Express HER2
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT05872295Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07392892Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06005493Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT06047379A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07069712Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT05523947Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
U tijeku regrutacijaFaza 2
Od 18 do 130 godina · Oba spola · Ažurirano 23. ruj 2026. · NCT05489211A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction Cancer
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT07631000Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.